SPC279
daratumumab, bortezomib, melphalan og prednisone
Status:
UmsóknApplication date:
9.10.2019Application published:
15.11.2019
Max expiry date:
25.9.2032Medicine name:
DarzalexMedicine for children:
No
Timeline
Today
9.10.2019Application
15.11.2019Publication
25.9.2032Expires
Marketing license
Foreign authorization number:
EU/1/16/1101/001/002Date:
18.12.2018
Owner
Name:
Genmab A/SAddress:
Carl Jacobsens Vej 30, Valby DK
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP2081595